CHRISTOPHER GARCIA: Open Payments
NPI 1013308535 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,356 in 45 payments from 19 companies in 2025. Trend: 2023 $2,802 · 2024 $3,483 · 2025 $3,356
Food & beverage: $2,781Travel & lodging: $476Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $1,113 |
| Boston Scientific Corporation | 8 | $897 |
| Sumitomo Pharma America, Inc. | 4 | $159 |
| AngioDynamics, Inc. | 1 | $154 |
| Novartis Pharmaceuticals Corporation | 1 | $140 |
| ABIOMED | 2 | $137 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Corcept Therapeutics | 1 | $110 |
| Novo Nordisk Inc | 2 | $100 |
| Telix Pharmaceuticals | 1 | $84 |
Products named: RYBREVANT, AdVance XP, ERLEADA, NANOKNIFE, WATCHMAN FLX, PLUVICTO, GEMTESA, Auvelity.
Industry payments across TX — which companies pay providers there.
